Cargando…
Potential Benefits and Harms of Novel Antidiabetic Drugs during COVID-19 Crisis
Patients with diabetes have been reported to have enhanced susceptibility to severe or fatal COVID-19 infections, including a high risk of being admitted to intensive care units with respiratory failure and septic complications. Given the global prevalence of diabetes, affecting over 450 million peo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277613/ https://www.ncbi.nlm.nih.gov/pubmed/32456064 http://dx.doi.org/10.3390/ijerph17103664 |